Foley Hoag represented Thermo Fisher Scientific in the acquisition. On December 30, 2021, Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, and PeproTech, Inc.,...
You must be a Standard 1 Year member to access this content.
Foley Hoag advised Shift5 on the deal. Shift5, an OT cybersecurity company that defends military platforms and commercial transportation systems from cyberattacks, closed a $20 million Series...
You must be a Standard 1 Year member to access this content.
Foley Hoag LLP advised Pear Therapeutics, Inc. on the deal. Pear Therapeutics, Inc., a pioneer of prescription digital therapeutics (PDTs), announced the extension of its Series D...
You must be a Standard 1 Year member to access this content.
